These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 33169429)
21. Spiro Diorthoester (SpiDo), a Human Plasma Stable Acid-Sensitive Cleavable Linker for Lysosomal Release. Leriche G; Nothisen M; Baumlin N; Muller CD; Bagnard D; Remy JS; Jacques SA; Wagner A Bioconjug Chem; 2015 Aug; 26(8):1461-5. PubMed ID: 26131605 [TBL] [Abstract][Full Text] [Related]
22. Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Pospisilik JA; Stafford SG; Demuth HU; Brownsey R; Parkhouse W; Finegood DT; McIntosh CH; Pederson RA Diabetes; 2002 Apr; 51(4):943-50. PubMed ID: 11916911 [TBL] [Abstract][Full Text] [Related]
23. Insulin concentrations and time-action profiles of three different intermediate-acting insulin preparations in nondiabetic volunteers under glucose-controlled glucose infusion technique. Bottermann P; Gyaram H; Wahl K; Ermler R; Lebender A Diabetes Care; 1982; 5 Suppl 2():43-52. PubMed ID: 6765540 [TBL] [Abstract][Full Text] [Related]
24. Pulsatile intravenous insulin replacement in streptozotocin diabetic rats is more efficient than continuous delivery: effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis. Koopmans SJ; Sips HC; Krans HM; Radder JK Diabetologia; 1996 Apr; 39(4):391-400. PubMed ID: 8777988 [TBL] [Abstract][Full Text] [Related]
25. Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties. Krug AW; Visser SAG; Tsai K; Kandala B; Fancourt C; Thornton B; Morrow L; Kaarsholm NC; Bernstein HS; Stoch SA; Crutchlow M; Kelley DE; Iwamoto M Clin Pharmacol Ther; 2019 Feb; 105(2):417-425. PubMed ID: 30125349 [TBL] [Abstract][Full Text] [Related]
26. In Silico Investigation of the Clinical Translatability of Competitive Clearance Glucose-Responsive Insulins. Yang JF; Yang S; Gong X; Bakh NA; Zhang G; Wang AB; Cherrington AD; Weiss MA; Strano MS ACS Pharmacol Transl Sci; 2023 Oct; 6(10):1382-1395. PubMed ID: 37854621 [TBL] [Abstract][Full Text] [Related]
27. Proteolytic Unlocking of Ultrastable Twin-Acylhydrazone Linkers for Lysosomal Acid-Triggered Release of Anticancer Drugs. Zheng Y; Ren J; Wu Y; Meng X; Zhao Y; Wu C Bioconjug Chem; 2017 Oct; 28(10):2620-2626. PubMed ID: 28922598 [TBL] [Abstract][Full Text] [Related]
28. Differential role of insulin receptor autophosphorylation sites 1162 and 1163 in the long-term insulin stimulation of glucose transport, glycogenesis, and protein synthesis. Desbois C; Capeau J; Hainault I; Wicek D; Reynet C; Veissière D; Caron M; Picard J; Guerre-Millo M; Cherqui G J Biol Chem; 1992 Jul; 267(19):13488-97. PubMed ID: 1618850 [TBL] [Abstract][Full Text] [Related]
29. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice. Liang Y; Cincotta AH Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153 [TBL] [Abstract][Full Text] [Related]
30. Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats. Holmäng A; Mimura K; Björntorp P; Lönnroth P Diabetes; 1997 Nov; 46(11):1799-804. PubMed ID: 9356029 [TBL] [Abstract][Full Text] [Related]
31. Connecting Rodent and Human Pharmacokinetic Models for the Design and Translation of Glucose-Responsive Insulin. Yang JF; Gong X; Bakh NA; Carr K; Phillips NFB; Ismail-Beigi F; Weiss MA; Strano MS Diabetes; 2020 Aug; 69(8):1815-1826. PubMed ID: 32152206 [TBL] [Abstract][Full Text] [Related]
32. Useful tools for biomolecule isolation, detection, and identification: acylhydrazone-based cleavable linkers. Park KD; Liu R; Kohn H Chem Biol; 2009 Jul; 16(7):763-72. PubMed ID: 19635413 [TBL] [Abstract][Full Text] [Related]
33. Pd(II)-catalyzed direct C-H acylation of N-Boc hydrazones with aldehydes: one-pot synthesis of 1,2-diacylbenzenes. Sharma S; Kim A; Park J; Kim M; Kwak JH; Jung YH; Park JS; Kim IS Org Biomol Chem; 2013 Dec; 11(45):7869-76. PubMed ID: 24129548 [TBL] [Abstract][Full Text] [Related]
35. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes? Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155 [TBL] [Abstract][Full Text] [Related]
36. Glycoinsulins: dendritic sialyloligosaccharide-displaying insulins showing a prolonged blood-sugar-lowering activity. Sato M; Furuike T; Sadamoto R; Fujitani N; Nakahara T; Niikura K; Monde K; Kondo H; Nishimura S J Am Chem Soc; 2004 Nov; 126(43):14013-22. PubMed ID: 15506764 [TBL] [Abstract][Full Text] [Related]
37. Use of mutant insulin receptors in structure-function studies of insulins. Schäffer L; Markussen J; Kjeldsen T; Andersen AS; Wiberg FC; Tager H Biochem Soc Trans; 1992 Nov; 20(4):842-3. PubMed ID: 1487077 [No Abstract] [Full Text] [Related]
38. Purification, characterization, and biological activity of insulins from the spotted dogfish, Scyliorhinus canicula, and the hammerhead shark, Sphyrna lewini. Anderson WG; Ali MF; Einarsdóttir IE; Schäffer L; Hazon N; Conlon JM Gen Comp Endocrinol; 2002 Mar; 126(1):113-22. PubMed ID: 11944972 [TBL] [Abstract][Full Text] [Related]
39. Engineering Glucose Responsiveness Into Insulin. Kaarsholm NC; Lin S; Yan L; Kelly T; van Heek M; Mu J; Wu M; Dai G; Cui Y; Zhu Y; Carballo-Jane E; Reddy V; Zafian P; Huo P; Shi S; Antochshuk V; Ogawa A; Liu F; Souza SC; Seghezzi W; Duffy JL; Erion M; Nargund RP; Kelley DE Diabetes; 2018 Feb; 67(2):299-308. PubMed ID: 29097375 [TBL] [Abstract][Full Text] [Related]